CenterWatch Logo Welcome to the Malecare, Inc. Clinical Trials Resource Center, presented in partnership with CenterWatch, the leading publisher of information on clinical research for patients and their advocates and healthcare professionals. Please click on the links below to learn more about clinical research and new medical therapies for treating oncology-related conditions.

About Clinical Research
This section provides background information about the clinical trials process and what to expect when you volunteer to participate in a clinical trial. Here, you'll find answers to frequently asked questions about clinical trials and also suggestions for where to find more information.

FDA Approved Drugs » 1999
Medical Areas: Oncology

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

Zofran

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoSmithKline
Approval Status: Approved January 1999
Treatment Area: Oncology

General Information

Zofran ODT (odansetron) Orally Disintegrating Tablets have been approved for prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.